New drug combo aims to boost stroke recovery in thousands
NCT ID NCT07369999
First seen Jan 29, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This study tests whether adding a neuroprotective drug (butylphthalide) to a standard clot-busting drug (tenecteplase) helps people with mild disabling stroke recover better. About 1,062 adults aged 18-80 who can be treated within 4.5 hours of symptoms will be randomly assigned to get either the combination or the standard drug alone. The main goal is to see if more people are free of disability 90 days after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD DISABLING ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.